Ascletis Pharma Inc. (OTCMKTS:ASCLF) Short Interest Update

Ascletis Pharma Inc. (OTCMKTS:ASCLF) was the target of a large drop in short interest in September. As of September 15th, there was short interest totaling 3,000 shares, a drop of 99.3% from the August 31st total of 453,000 shares. Based on an average daily volume of 300 shares, the days-to-cover ratio is presently 10.0 days. Based on an average daily volume of 300 shares, the days-to-cover ratio is presently 10.0 days.

Ascletis Pharma Stock Performance

Shares of ASCLF opened at $1.22 on Wednesday. Ascletis Pharma has a twelve month low of $0.16 and a twelve month high of $1.98. The firm’s 50-day moving average is $1.60 and its two-hundred day moving average is $1.18.

About Ascletis Pharma

Ascletis Pharma Inc, a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company offers Ritonavir tablet; and ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis.